Back
Speaker illustration

Doctor John R Nelson

California Cardiovascular Institute, Fresno (United States of America)

Presentations

Cross-sectional analysis of demographic and clinical characteristics of patients using icosapent ethyl

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session: Hypertriglyceridemia treatment: CEPT, icosapent ethyl, and fibrates

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources